What it isHigh-potency GABA-A positive allosteric modulator; panic disorder and anxiety.
Why this oneRapid onset and short duration relieve panic quickly but create more interdose rebound than longer-acting benzodiazepines.
What limits itDependence can develop quickly; taper slowly to avoid severe withdrawal. Opioids and other sedatives can cause fatal respiratory depression.
BOXED WARNING Concomitant opioids may cause profound sedation, respiratory depression, coma, death. Benzodiazepine abuse/misuse/addiction can lead to overdose or death. Dependence and life-threatening withdrawal—taper gradually.
FDA dosing
Population
Start
Target
Max
Generalized anxiety disorder
Adult
0.25–0.5 mg TID
—
4 mg/day divided
Panic disorder
Adult
0.5 mg TID
5–6 mg/day
10 mg/day
Anxiety / panic
Geriatric
0.25 mg BID–TID
—
—
Titration GAD: adjust every 3–4 days. Panic: increase every 3–4 days by ≤1 mg/day.
Renal Undefined
Hepatic Start 0.25 mg 2–3×/day; reduce dose.
Instructions
Taper to discontinue: decrease by ≤0.5 mg every 3 days (slower if needed).
Avoid alcohol and other CNS depressants.
With ritonavir, halve dose initially then increase after 10–14 days; contraindicated with other strong CYP3A inhibitors.